The European health regulator endorsed the use of widely known steroid dexamethasone in the treatment of COVID-19 patients on oxygen or mechanical ventilation.

The European Medicines Agency (EMA) said based on its review of results of a study by UK researchers, it concluded that dexamethasone – a commonly used drug against a range of inflammatory conditions – can be considered a treatment option in adults and adolescents needing oxygen therapy.

The recommended dose in adults and adolescents, from 12 years of age and weighing at least 40kg, is 6 milligrams once a day for up to 10 days, the EMA said. 

Aljazeera

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.